Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00227123 · ClinicalTrials.gov registry record · NA
A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT00227123 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 96 participants.
The verdict
NCT00227123, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether quetiapine or risperidone are effective in treating mood symptoms, drug cravings and use in bipolar disorder with concurrent cocaine or methamphetamine dependence.
Interventions
- DRUG quetiapine, risperidone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2002-10 |
| Est. Completion | 2006-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00227123
The ClinicalTrials.gov registry entry for NCT00227123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which quetiapine, risperidone is the first listed.
NCT00227123 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00227123 about?
NCT00227123 is a clinical study titled "A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence". The purpose of this study is to determine whether quetiapine or risperidone are effective in treating mood symptoms, drug cravings and use in bipolar disorder with concurrent cocaine or methamphetamine dependence.
What is the current status of trial NCT00227123?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2002-10. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00227123?
The interventions under investigation include: quetiapine, risperidone (DRUG).
Who is sponsoring clinical trial NCT00227123?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.